Kiss, Izabella <br/><br/>
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.  [electronic resource] 

 -  Cancer letters  Jan 2015 
 - 994-1006 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2014.11.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis--drug effects<br/>Asteraceae--chemistry<br/>Blotting, Western<br/>Caspases--genetics<br/>Cell Cycle--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--genetics<br/>Endothelium, Lymphatic--drug effects<br/>Humans<br/>Leukocytes, Mononuclear--drug effects<br/>Lymphoma, Large-Cell, Anaplastic--drug therapy<br/>Mitochondria--drug effects<br/>NF-kappa B--antagonists & inhibitors<br/>Neoplasm Invasiveness<br/>Plant Extracts--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-jun--genetics<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sesquiterpenes--pharmacology<br/>Tumor Cells, Cultured